COMMUNIQUÉS West-GlobeNewswire

Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

18/10/2018 - 13:30

EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster [...]

Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference

18/10/2018 - 13:30

-- Findings support ongoing Phase 1/2 study of once-weekly nebulized MRT5005 in adults with cystic fibrosis -- LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage [...]

MSI Methylation Sciences, Inc. (MSI) provides an update on its corporate activities, including its recent arbitration award of $20 million USD against Quark Venture Inc (Quark)

18/10/2018 - 13:06

BURNABY, B.C., Oct. 18, 2018 (GLOBE NEWSWIRE) -- In a January 2016 press release, MSI announced the results of its first Phase 2 clinical trial designed to evaluate the efficacy and safety of MSI-195 (Strada™) relative [...]

Bendcare Endorses Vectra® Testing for Patients with Rheumatoid Arthritis

18/10/2018 - 13:05

Vectra Provides Important Information to Help Rheumatologists Identify Patients at Increased Risk of Joint Damage SALT LAKE CITY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader [...]

Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe

18/10/2018 - 13:00

SAN CARLOS, Calif. and GOSSELIES, Belgium , Oct. 18, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor infiltrating [...]

EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ™ to be Presented at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting

18/10/2018 - 13:00

- Five oral abstracts to be presented at annual meeting and subspecialty days – -24-month follow up YUTIQ data to be highlighted at a breakthrough presentation- WATERTOWN, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- [...]

T2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date

18/10/2018 - 13:00

LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq: TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare [...]

Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018

18/10/2018 - 13:00

CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]

Notice of Results

18/10/2018 - 13:00

Shire to announce third quarter 2018 results Dublin, Ireland – October 18, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2018 earnings on Thursday November 1, 2018. Results press release will be [...]

Homology Medicines Presents Long-Term Efficacy Data of a Single Dose of Gene Therapy Development Candidate for Treatment of Phenylketonuria

18/10/2018 - 13:00

BEDFORD, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today long-term efficacy data of a single dose of its lead gene therapy candidate for the [...]

Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Alzheimer’s Disease Agitation

18/10/2018 - 13:00

NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

Pluristem Therapeutics Selected to Present Data from Phase II IC Study at the American Heart Association Scientific Sessions

18/10/2018 - 12:30

The Company will also present at the BioEurope, Annual Vascular Interventional Advances and Cell and Gene Therapy Manufacturing conferences, all held in November HAIFA, Israel, Oct. 18, 2018 (GLOBE NEWSWIRE) -- [...]

Avivagen Announces Distribution Agreement for Vivamune™ in Vietnam

18/10/2018 - 12:30

OTTAWA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has entered into a distribution agreement for Vivamune™ Health Chews in the Vietnamese market with Viphavet [...]

Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)

18/10/2018 - 08:31

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Press release Lund on October 18, 2018 Notice of [...]

Sales of Olainfarm Group in Nine Month Increase By 4%.

18/10/2018 - 08:18

Consolidated Results of September and 9 months of 2018 Preliminary consolidated Olainfarm Group sales in September 2018 reached 9.5 million euros, which represents a slight decrease of 1% compared to sales of September [...]

Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China

18/10/2018 - 08:00

LONDON, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in combination with [...]

Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million

18/10/2018 - 08:00

Press release October 18, 2018 The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million The Board of Directors of Enzymatica AB (publ) has decided to carry out a rights issue of a maximum of [...]

Rule 2.9 Announcement

18/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 October 2018 [...]

Enzymatica AB: Enzymatica signs agreement for the Japanese market

18/10/2018 - 07:31

Press release October 18, 2018 Enzymatica signs agreement for the Japanese market Enzymatica has entered into an agreement with a large Japanese pharmaceutical company regarding registration, marketing, distribution and [...]